@Davisite Dr.T I'm a little confusedby this reply as RAC announced 3rd Nov 2021 "Race Initiates University Of Newcastle Collaboration To Develop A Genomics-Based Companion Diagnostic For Zantrene" and 27th Oct 2021 Sheba biomarker collaboration was also announced..
AFAIK there has been no reported outcomes from either of these collaborations.
Is there are reason for this you can share, or can't because of PS or patent being prepared. ?
Are you also suggesting that the planned trials will test for FTO using the biomarkers or diagnostics created from those collaborations ?
Thanks
d.
Pillar 1 - FTO (new thread), page-2873
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.01 |
Change
0.260(14.9%) |
Mkt cap ! $350.7M | |||
| Open | High | Low | Value | Volume |
| $1.87 | $2.08 | $1.86 | $1.269M | 645.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 505 | $1.98 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.02 | 4543 | 2 |
View Market Depth
| Last trade - 16.10pm 18/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$2.02 |
Change
0.260 ( 16.2 %) |
||||
| Open | High | Low | Volume | ||
| $1.86 | $2.08 | $1.86 | 50369 | ||
| Last updated 15.59pm 18/06/2024 ? | |||||
| RAC (ASX) Chart |